Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

被引：0
|
作者：
Marie-Theres Kassik
Dirk Vordermark
Christine Kornhuber
Daniel Medenwald
机构：
[1] University Hospital Halle/Saale,Department of Radiation Therapy
来源：
Radiation Oncology | / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
    Taniguchi, Yoshihiko
    Tamiya, Akihiro
    Isa, Syun-Ichi
    Nakahama, Kenji
    Okishio, Kyoichi
    Shiroyama, Takayuki
    Suzuki, Hidekazu
    Inoue, Takako
    Tamiya, Motohiro
    Hirashima, Tomonori
    Imamura, Fumio
    Atagi, Shinji
    ANTICANCER RESEARCH, 2017, 37 (10) : 5857 - 5862
  • [32] Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
    Halabi, Susan
    Roy, Akash
    Rydzewska, Larysa
    Guo, Siyuan
    Godolphin, Peter
    Hussain, Maha
    Tangen, Catherine
    Thompson, Ian
    Xie, Wanling
    Carducci, Michael A.
    Smith, Matthew R.
    Morris, Michael J.
    Gravis, Gwenaelle
    Dearnaley, David P.
    Verhagen, Paul
    Goto, Takayuki
    James, Nick
    Buyse, Marc E.
    Tierney, Jayne F.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09)
  • [33] Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
    Takaya Yamamoto
    Yoko Tsukita
    Yu Katagiri
    Haruo Matsushita
    Rei Umezawa
    Yojiro Ishikawa
    Noriyoshi Takahashi
    Yu Suzuki
    Kazuya Takeda
    Eisaku Miyauchi
    Ryota Saito
    Yoshiyuki Katsuta
    Noriyuki Kadoya
    Keiichi Jingu
    BMC Cancer, 22
  • [34] Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
    Yamamoto, Takaya
    Tsukita, Yoko
    Katagiri, Yu
    Matsushita, Haruo
    Umezawa, Rei
    Ishikawa, Yojiro
    Takahashi, Noriyoshi
    Suzuki, Yu
    Takeda, Kazuya
    Miyauchi, Eisaku
    Saito, Ryota
    Katsuta, Yoshiyuki
    Kadoya, Noriyuki
    Jingu, Keiichi
    BMC CANCER, 2022, 22 (01)
  • [35] Real-world Disease-Free Survival as a Predictor of Overall Survival in Resected Early-Stage Non-Small Cell Lung Cancer
    West, H.
    Hu, X.
    Chirovsky, D.
    Song, Y.
    Zhang, S.
    Gao, C.
    Carley, C.
    Lerner, A.
    Signorovitch, J.
    Samkari, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S219 - S220
  • [36] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
  • [37] Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies
    Araki, Tomonori
    Kawahira, Machiko
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Hayashi, Kohei
    Sonoda, Yuki
    Honda, Takuya
    Nakao, Kazuhiko
    Shibuki, Taro
    Nakazawa, Junichi
    Arima, Shiho
    Fukahori, Masaru
    Miwa, Keisuke
    Koga, Futa
    Ueda, Yujiro
    Kubotsu, Yoshihito
    Makiyama, Akitaka
    Shimokawa, Hozumi
    Takeshita, Shigeyuki
    Nishikawa, Kazuo
    Komori, Azusa
    Otsu, Satoshi
    Hosokawa, Ayumu
    Sakai, Tatsunori
    Oda, Hisanobu
    Arita, Shuji
    Taguchi, Hiroki
    Tsuneyoshi, Kengo
    Kawaguchi, Yasunori
    Fujita, Toshihiro
    Sakae, Takahiro
    Nio, Kenta
    Ide, Yasushi
    Ureshino, Norio
    Shirakawa, Tsuyoshi
    Mizuta, Toshihiko
    Mitsugi, Kenji
    ONCOLOGY, 2024,
  • [38] EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Bramuzzo, I.
    Gerussi, A.
    Maier, S.
    Bianco, C.
    Romanin, A.
    Pasini, C. Laghi
    Barghini, V.
    Scata, L.
    Donnini, D.
    Uzzau, A.
    Vit, A.
    Sechi, L. A.
    Soardo, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E217 - E217
  • [39] DIFFERENCES IN CORRELATION OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL BY CLINICAL VARIABLES IN EPITHELIAL OVARIAN CANCER
    Paik, E. S.
    Jeong, S. Y.
    Kim, M. S.
    Kim, J. H.
    Kim, T. J.
    Lee, J. W.
    Kim, B. G.
    Bae, D. S.
    Choi, C. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 717 - 717
  • [40] DIFFERENCES IN CORRELATION OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL BY CLINICAL VARIABLES IN EPITHELIAL OVARIAN CANCER
    Paik, E. S.
    Kang, M.
    Lee, J. H.
    Kang, J. H.
    Jeong, S. Y.
    Kim, M. S.
    Lee, Y-Y
    Kim, T-J
    Lee, J-W
    Kim, B-G
    Bae, D-S
    Seo, J.
    Choi, C. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A504 - A505
12345